Last reviewed · How we verify

NCT04311333: CTULOP

Endostomal Three-dimensional Ultrasonography for Parastomal Hernia

Status unknown NA Last updated 4 November 2020
What this trial tests

NA trial testing Endostomal three-dimensional ultrasonography in Parastomal Hernia in 100 participants. Status unknown.

Timeline
27 September 2016
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorUmeå University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment100
Start date27 September 2016
Primary completion31 December 2021
Estimated completion31 December 2021
Sites3 locations across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Umeå University

Who can join

18 and older, any sex, with Parastomal Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The intention is to examine the role of ultrasonographic examination inside intestinal stomas in diagnosing parastomal hernia. Patients with a stoma since at least one year back who are being scheduled for abdominal surgery will be examined for eligibility according to the selection criteria. Included patients will undergo routine clinical examination, endostomal ultrasonography and computerized tomography scan of the abdomen. Findings will be correlated to findings during surgery (gold standard). Values for sensitivity, specificity, predictive values and likelihood ratio will be calculated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Parastomal Hernia

Currently open trials in the same condition.

Other Umeå University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04311333.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing